EATBF yields 2567.39% · JNJ yields 2.13%● Live data
📍 EATBF pulled ahead of the other in Year 1
Combined, EATBF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EATBF + JNJ for your $10,000?
Eat & Beyond Global Holdings Inc. is a private equity and venture capital firm specializing in early stage, growth, expansion, buy-ins or buy-out investments. It focuses on investments in the plant-based protein and meat alternative food industry. It identifies and acquires equity in companies operating in the sectors of plant-based proteins, fermented proteins, cultured proteins/agriculture, food tech, and consumer packaged goods, as well as cell agriculture and other experimental projects. The firm prefers to invest in companies based in North America, Europe, Israel, and Asian and Latin American countries. It typically invests between $1 million and $10million over the initial 48-month deployment period with a minimum ownership goal of 5%+. It prefers to take majority stakes. Eat & Beyond Global Holdings Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada.
Full EATBF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.